ConductScience.org, home

Paper35840985

Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.

Wang Y and 8 others. World J Surg Oncol, 2022. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma. Papers, record 35840985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35840985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
PubMed
Journal
World J Surg Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.16
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYu
2Song TTongjun
3Li KKai
4Liu HHao
5Han YYan
6Xu TTao
7Cao FFengjun
8Li YYong
9Yu YYuandong

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Esophageal NeoplasmsMajor topic
Esophageal Squamous Cell CarcinomaMajor topic
Biomarkers, Tumor
Computational Biology
Gene Expression Regulation, Neoplastic
Glucuronidase
Humans
Hypoxia
Immunohistochemistry
Prognosis
Tumor Microenvironment
Heparanase

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118273037Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.Nat Rev Cancer2008https://conductscience.org/library/papers/18273037PubMed
232375686Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.BMC Cancer2020https://conductscience.org/library/papers/32375686PubMed
322952874Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.PLoS One2012https://conductscience.org/library/papers/22952874PubMed
411395850Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.Semin Oncol2001https://conductscience.org/library/papers/11395850PubMed
524862152Heparanase multiple effects in cancer.Thromb Res2014https://conductscience.org/library/papers/24862152PubMed
617891338A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.Invest New Drugs2008https://conductscience.org/library/papers/17891338PubMed
716901744Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.Int J Biochem Cell Biol2006https://conductscience.org/library/papers/16901744PubMed
88707262Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.Hepatology1996https://conductscience.org/library/papers/8707262PubMed
919303160Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage.J Hepatol2009https://conductscience.org/library/papers/19303160PubMed
1029145629The Reactome Pathway Knowledgebase.Nucleic Acids Res2018https://conductscience.org/library/papers/29145629PubMed
1131166985Understanding heterogeneous tumor microenvironment in metastatic melanoma.PLoS One2019https://conductscience.org/library/papers/31166985PubMed
1222507220Epidemiologic differences in esophageal cancer between Asian and Western populations.Chin J Cancer2012https://conductscience.org/library/papers/22507220PubMed
1332820608GSVA score reveals molecular signatures from transcriptomes for biomaterials comparison.J Biomed Mater Res A2021https://conductscience.org/library/papers/32820608PubMed
1429290801RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.Theranostics2018https://conductscience.org/library/papers/29290801PubMed
1517440684Hypoxia in cancer: significance and impact on clinical outcome.Cancer Metastasis Rev2007https://conductscience.org/library/papers/17440684PubMed
1633092083A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.Cancers (Basel)2020https://conductscience.org/library/papers/33092083PubMed
1726409826Integrative genomics analysis of genes with biallelic loss and its relation to the expression of mRNA and micro-RNA in esophageal squamous cell carcinoma.BMC Genomics2015https://conductscience.org/library/papers/26409826PubMed
1824522499LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.Gut2014https://conductscience.org/library/papers/24522499PubMed
1928536608Nuclear expression of TCF4/TCF7L2 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.Cell Mol Biol Lett2016https://conductscience.org/library/papers/28536608PubMed
208813149Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.Cancer Res1996https://conductscience.org/library/papers/8813149PubMed

See all 42 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40059241Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study.Sci Rep2025https://conductscience.org/library/papers/40059241PubMed
39248214Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins.Technol Cancer Res Treat2024https://conductscience.org/library/papers/39248214PubMed
36817484Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.Front Immunol2023https://conductscience.org/library/papers/36817484PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35840985

GET https://conductscience.org/api/papers/v1/35840985/references?page=2